Search research articles
Contact Us
Filters
Showing results (301-310 of 357) with videos related to
Page
of 36
Sort By:
NEJM Evidence
|
September 23, 2025
Cendakimab in Adults and Adolescents with Eosinophilic Esophagitis
Evan S Dellon, Christina M Charriez, Sandra Zhang, et al.
Inflammatory Bowel Diseases
|
March 23, 2017
Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort Study
Christopher Ma, Richard N Fedorak, Gilaad G Kaplan, et al.
Journal of Crohn'S & Colitis
|
May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus
Pauline Wils, Vipul Jairath, Bruce E Sands, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 30, 2018
Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review
Christopher Ma, Isra M Hussein, Yousef J Al-Abbar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 4, 2025
Diagnostic Accuracy of Noninvasive Biomarkers and Imaging for Evaluating Postoperative Recurrence in Crohn's Disease
Sunil Samnani, Christina M Ray, Priyanka Gill, et al.
The American Journal of Gastroenterology
|
June 5, 2025
Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study
Virginia Solitano, Ropo Ebenezer Ogunsakin, Yuhong Yuan, et al.
Journal of the Canadian Association of Gastroenterology
|
July 12, 2019
Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn's Disease: A Canadian Multi-Centre Observational Cohort Study
Hang Hock Shim, Christopher Ma, Paulo G Kotze, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 6, 2023
Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn's Disease Activity
Virginia Solitano, David F Schaeffer, Malcolm Hogan, et al.
Alimentary Pharmacology & Therapeutics
|
June 19, 2025
Systematic Review: Variability in Definitions of Fibrostenosis in Eosinophilic Oesophagitis
Claire A Beveridge, Natalie Farha, Christina Hermanns, et al.
Alimentary Pharmacology & Therapeutics
|
August 1, 2018
Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease
Paulo G Kotze, Christopher Ma, Abdulelah Almutairdi, et al.
Page
of 36
Search research articles
Search
Showing results (301-310 of 357) with videos related to
Sort By:
Page
of 36
NEJM Evidence
|
September 23, 2025
Cendakimab in Adults and Adolescents with Eosinophilic Esophagitis
Evan S Dellon, Christina M Charriez, Sandra Zhang, et al.
Inflammatory Bowel Diseases
|
March 23, 2017
Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort Study
Christopher Ma, Richard N Fedorak, Gilaad G Kaplan, et al.
Journal of Crohn'S & Colitis
|
May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus
Pauline Wils, Vipul Jairath, Bruce E Sands, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 30, 2018
Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review
Christopher Ma, Isra M Hussein, Yousef J Al-Abbar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 4, 2025
Diagnostic Accuracy of Noninvasive Biomarkers and Imaging for Evaluating Postoperative Recurrence in Crohn's Disease
Sunil Samnani, Christina M Ray, Priyanka Gill, et al.
The American Journal of Gastroenterology
|
June 5, 2025
Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study
Virginia Solitano, Ropo Ebenezer Ogunsakin, Yuhong Yuan, et al.
Journal of the Canadian Association of Gastroenterology
|
July 12, 2019
Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn's Disease: A Canadian Multi-Centre Observational Cohort Study
Hang Hock Shim, Christopher Ma, Paulo G Kotze, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 6, 2023
Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn's Disease Activity
Virginia Solitano, David F Schaeffer, Malcolm Hogan, et al.
Alimentary Pharmacology & Therapeutics
|
June 19, 2025
Systematic Review: Variability in Definitions of Fibrostenosis in Eosinophilic Oesophagitis
Claire A Beveridge, Natalie Farha, Christina Hermanns, et al.
Alimentary Pharmacology & Therapeutics
|
August 1, 2018
Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease
Paulo G Kotze, Christopher Ma, Abdulelah Almutairdi, et al.
Page
of 36